Non-specific vaccination exerts anti-tumor effect through CD11c (+) cells stimulation in a breast cancer model
- Autores
- de Gregorio, Vanessa Elizabeth; Carino, Silvia; Valdéz, Juan Carlos; Castillo, Silvio Eugenio; de Moreno, Maria Alejandra
- Año de publicación
- 2016
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: Immunotherapy by using non-specific vaccines has proven to be effective in experimental animal models and also in patients suffering cancer. In the present work, the effectiveness of this immunotherapy was evaluated using a murine breast cancer model and a polymicrobial vaccine. Methodology/Principal: Mice bearing injected with tumor cells from the spontaneous syngeneic mammary adeno carcinoma M3 were used as breast cancer model. The immune adjuvant effect of the vaccine was analyzed in comparison or in the presence of doxorubicin. Tumor volume was calculated. Tumor, spleen and lymph nodes were processed for histological observations and to determinate the percentage of CD11c (+) cells. Results: Mice treated with the vaccine or with doxorubicin decreased tumor growth, with less tumor cell invasion. Tumor tissues showed decreased necrosis and nuclear areas in mice that received any of the treatments under study, compared with the control group. The benefits of vaccination were associated to stimulation of the immune response. More hyperplasia of the red and white pulp, and increased marginal megakaryocytes were observed in the spleens from mice treated with the vaccine. CD11c (+) cells did not increase in tumor draining nodes by the immune stimulating effect of the vaccine; however, his treatment increased CD11c (+) cells in the spleen and tumor. Conclusions: A non-specific vaccine used as immunotherapy can be used to prolong an equilibrium phase in he tumor growth, similar to the doxorubicin treatment used in the model, although by different mechanisms. Non synergic effect was observed in the group treated with both vaccine and doxorubicin (low dose). Future studies should be necessary to evaluate the correct combination of vaccination and cytotoxic drug can be used for this purpose and to achieve increased activated dendritic cells in the tumor draining lymph nodes.
Fil: de Gregorio, Vanessa Elizabeth. Universidad Nacional de Tucumán. Facultad de Odontología; Argentina
Fil: Carino, Silvia. Universidad Nacional de Tucumán. Facultad de Odontología; Argentina
Fil: Valdéz, Juan Carlos. Universidad Nacional de Tucuman. Facultad de Bioquimica, Quimica y Farmacia. Instituto de Microbiologia. Cátedra de Inmunología; Argentina
Fil: Castillo, Silvio Eugenio. Universidad Nacional de Tucumán. Facultad de Ciencias Naturales e Instituto Miguel Lillo; Argentina
Fil: de Moreno, Maria Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucuman. Centro de Referencia Para Lactobacilos; Argentina - Materia
-
BREAST CANCER
IMMUNE RESPONSE
VACCINE
DENDRITIC CELLS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- Atribución-NoComercial-CompartirIgual 2.5 Argentina (CC BY-NC-SA 2.5 AR)
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/29304
Ver los metadatos del registro completo
id |
CONICETDig_669802bc6a91f236079a8de90052a553 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/29304 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Non-specific vaccination exerts anti-tumor effect through CD11c (+) cells stimulation in a breast cancer modelde Gregorio, Vanessa ElizabethCarino, SilviaValdéz, Juan CarlosCastillo, Silvio Eugeniode Moreno, Maria AlejandraBREAST CANCERIMMUNE RESPONSEVACCINEDENDRITIC CELLShttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Background: Immunotherapy by using non-specific vaccines has proven to be effective in experimental animal models and also in patients suffering cancer. In the present work, the effectiveness of this immunotherapy was evaluated using a murine breast cancer model and a polymicrobial vaccine. Methodology/Principal: Mice bearing injected with tumor cells from the spontaneous syngeneic mammary adeno carcinoma M3 were used as breast cancer model. The immune adjuvant effect of the vaccine was analyzed in comparison or in the presence of doxorubicin. Tumor volume was calculated. Tumor, spleen and lymph nodes were processed for histological observations and to determinate the percentage of CD11c (+) cells. Results: Mice treated with the vaccine or with doxorubicin decreased tumor growth, with less tumor cell invasion. Tumor tissues showed decreased necrosis and nuclear areas in mice that received any of the treatments under study, compared with the control group. The benefits of vaccination were associated to stimulation of the immune response. More hyperplasia of the red and white pulp, and increased marginal megakaryocytes were observed in the spleens from mice treated with the vaccine. CD11c (+) cells did not increase in tumor draining nodes by the immune stimulating effect of the vaccine; however, his treatment increased CD11c (+) cells in the spleen and tumor. Conclusions: A non-specific vaccine used as immunotherapy can be used to prolong an equilibrium phase in he tumor growth, similar to the doxorubicin treatment used in the model, although by different mechanisms. Non synergic effect was observed in the group treated with both vaccine and doxorubicin (low dose). Future studies should be necessary to evaluate the correct combination of vaccination and cytotoxic drug can be used for this purpose and to achieve increased activated dendritic cells in the tumor draining lymph nodes.Fil: de Gregorio, Vanessa Elizabeth. Universidad Nacional de Tucumán. Facultad de Odontología; ArgentinaFil: Carino, Silvia. Universidad Nacional de Tucumán. Facultad de Odontología; ArgentinaFil: Valdéz, Juan Carlos. Universidad Nacional de Tucuman. Facultad de Bioquimica, Quimica y Farmacia. Instituto de Microbiologia. Cátedra de Inmunología; ArgentinaFil: Castillo, Silvio Eugenio. Universidad Nacional de Tucumán. Facultad de Ciencias Naturales e Instituto Miguel Lillo; ArgentinaFil: de Moreno, Maria Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucuman. Centro de Referencia Para Lactobacilos; ArgentinaClinMed International Library2016-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/29304de Gregorio, Vanessa Elizabeth; Carino, Silvia; Valdéz, Juan Carlos; Castillo, Silvio Eugenio; de Moreno, Maria Alejandra; Non-specific vaccination exerts anti-tumor effect through CD11c (+) cells stimulation in a breast cancer model; ClinMed International Library; International Journal of Immunology and Immunotherapy; 3; 2; 12-2016; 1-6;025-0252378-3672CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.23937/2378-3672/1410025info:eu-repo/semantics/altIdentifier/url/https://clinmedjournals.org/articles/ijii/international-journal-of-immunology-and-immunotherapy-ijii-3-025.pdfinfo:eu-repo/semantics/altIdentifier/url/https://clinmedjournals.org/articles/ijii/international-journal-of-immunology-and-immunotherapy-ijii-3-025.php?jid=ijiiinfo:eu-repo/semantics/openAccessAtribución-NoComercial-CompartirIgual 2.5 Argentina (CC BY-NC-SA 2.5 AR)https://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:10:51Zoai:ri.conicet.gov.ar:11336/29304instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:10:51.658CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Non-specific vaccination exerts anti-tumor effect through CD11c (+) cells stimulation in a breast cancer model |
title |
Non-specific vaccination exerts anti-tumor effect through CD11c (+) cells stimulation in a breast cancer model |
spellingShingle |
Non-specific vaccination exerts anti-tumor effect through CD11c (+) cells stimulation in a breast cancer model de Gregorio, Vanessa Elizabeth BREAST CANCER IMMUNE RESPONSE VACCINE DENDRITIC CELLS |
title_short |
Non-specific vaccination exerts anti-tumor effect through CD11c (+) cells stimulation in a breast cancer model |
title_full |
Non-specific vaccination exerts anti-tumor effect through CD11c (+) cells stimulation in a breast cancer model |
title_fullStr |
Non-specific vaccination exerts anti-tumor effect through CD11c (+) cells stimulation in a breast cancer model |
title_full_unstemmed |
Non-specific vaccination exerts anti-tumor effect through CD11c (+) cells stimulation in a breast cancer model |
title_sort |
Non-specific vaccination exerts anti-tumor effect through CD11c (+) cells stimulation in a breast cancer model |
dc.creator.none.fl_str_mv |
de Gregorio, Vanessa Elizabeth Carino, Silvia Valdéz, Juan Carlos Castillo, Silvio Eugenio de Moreno, Maria Alejandra |
author |
de Gregorio, Vanessa Elizabeth |
author_facet |
de Gregorio, Vanessa Elizabeth Carino, Silvia Valdéz, Juan Carlos Castillo, Silvio Eugenio de Moreno, Maria Alejandra |
author_role |
author |
author2 |
Carino, Silvia Valdéz, Juan Carlos Castillo, Silvio Eugenio de Moreno, Maria Alejandra |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
BREAST CANCER IMMUNE RESPONSE VACCINE DENDRITIC CELLS |
topic |
BREAST CANCER IMMUNE RESPONSE VACCINE DENDRITIC CELLS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Background: Immunotherapy by using non-specific vaccines has proven to be effective in experimental animal models and also in patients suffering cancer. In the present work, the effectiveness of this immunotherapy was evaluated using a murine breast cancer model and a polymicrobial vaccine. Methodology/Principal: Mice bearing injected with tumor cells from the spontaneous syngeneic mammary adeno carcinoma M3 were used as breast cancer model. The immune adjuvant effect of the vaccine was analyzed in comparison or in the presence of doxorubicin. Tumor volume was calculated. Tumor, spleen and lymph nodes were processed for histological observations and to determinate the percentage of CD11c (+) cells. Results: Mice treated with the vaccine or with doxorubicin decreased tumor growth, with less tumor cell invasion. Tumor tissues showed decreased necrosis and nuclear areas in mice that received any of the treatments under study, compared with the control group. The benefits of vaccination were associated to stimulation of the immune response. More hyperplasia of the red and white pulp, and increased marginal megakaryocytes were observed in the spleens from mice treated with the vaccine. CD11c (+) cells did not increase in tumor draining nodes by the immune stimulating effect of the vaccine; however, his treatment increased CD11c (+) cells in the spleen and tumor. Conclusions: A non-specific vaccine used as immunotherapy can be used to prolong an equilibrium phase in he tumor growth, similar to the doxorubicin treatment used in the model, although by different mechanisms. Non synergic effect was observed in the group treated with both vaccine and doxorubicin (low dose). Future studies should be necessary to evaluate the correct combination of vaccination and cytotoxic drug can be used for this purpose and to achieve increased activated dendritic cells in the tumor draining lymph nodes. Fil: de Gregorio, Vanessa Elizabeth. Universidad Nacional de Tucumán. Facultad de Odontología; Argentina Fil: Carino, Silvia. Universidad Nacional de Tucumán. Facultad de Odontología; Argentina Fil: Valdéz, Juan Carlos. Universidad Nacional de Tucuman. Facultad de Bioquimica, Quimica y Farmacia. Instituto de Microbiologia. Cátedra de Inmunología; Argentina Fil: Castillo, Silvio Eugenio. Universidad Nacional de Tucumán. Facultad de Ciencias Naturales e Instituto Miguel Lillo; Argentina Fil: de Moreno, Maria Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucuman. Centro de Referencia Para Lactobacilos; Argentina |
description |
Background: Immunotherapy by using non-specific vaccines has proven to be effective in experimental animal models and also in patients suffering cancer. In the present work, the effectiveness of this immunotherapy was evaluated using a murine breast cancer model and a polymicrobial vaccine. Methodology/Principal: Mice bearing injected with tumor cells from the spontaneous syngeneic mammary adeno carcinoma M3 were used as breast cancer model. The immune adjuvant effect of the vaccine was analyzed in comparison or in the presence of doxorubicin. Tumor volume was calculated. Tumor, spleen and lymph nodes were processed for histological observations and to determinate the percentage of CD11c (+) cells. Results: Mice treated with the vaccine or with doxorubicin decreased tumor growth, with less tumor cell invasion. Tumor tissues showed decreased necrosis and nuclear areas in mice that received any of the treatments under study, compared with the control group. The benefits of vaccination were associated to stimulation of the immune response. More hyperplasia of the red and white pulp, and increased marginal megakaryocytes were observed in the spleens from mice treated with the vaccine. CD11c (+) cells did not increase in tumor draining nodes by the immune stimulating effect of the vaccine; however, his treatment increased CD11c (+) cells in the spleen and tumor. Conclusions: A non-specific vaccine used as immunotherapy can be used to prolong an equilibrium phase in he tumor growth, similar to the doxorubicin treatment used in the model, although by different mechanisms. Non synergic effect was observed in the group treated with both vaccine and doxorubicin (low dose). Future studies should be necessary to evaluate the correct combination of vaccination and cytotoxic drug can be used for this purpose and to achieve increased activated dendritic cells in the tumor draining lymph nodes. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-12 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/29304 de Gregorio, Vanessa Elizabeth; Carino, Silvia; Valdéz, Juan Carlos; Castillo, Silvio Eugenio; de Moreno, Maria Alejandra; Non-specific vaccination exerts anti-tumor effect through CD11c (+) cells stimulation in a breast cancer model; ClinMed International Library; International Journal of Immunology and Immunotherapy; 3; 2; 12-2016; 1-6;025-025 2378-3672 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/29304 |
identifier_str_mv |
de Gregorio, Vanessa Elizabeth; Carino, Silvia; Valdéz, Juan Carlos; Castillo, Silvio Eugenio; de Moreno, Maria Alejandra; Non-specific vaccination exerts anti-tumor effect through CD11c (+) cells stimulation in a breast cancer model; ClinMed International Library; International Journal of Immunology and Immunotherapy; 3; 2; 12-2016; 1-6;025-025 2378-3672 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.23937/2378-3672/1410025 info:eu-repo/semantics/altIdentifier/url/https://clinmedjournals.org/articles/ijii/international-journal-of-immunology-and-immunotherapy-ijii-3-025.pdf info:eu-repo/semantics/altIdentifier/url/https://clinmedjournals.org/articles/ijii/international-journal-of-immunology-and-immunotherapy-ijii-3-025.php?jid=ijii |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess Atribución-NoComercial-CompartirIgual 2.5 Argentina (CC BY-NC-SA 2.5 AR) https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
Atribución-NoComercial-CompartirIgual 2.5 Argentina (CC BY-NC-SA 2.5 AR) https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
ClinMed International Library |
publisher.none.fl_str_mv |
ClinMed International Library |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842270134870212608 |
score |
13.13397 |